Home › NDC Lookup › RxCUI directory › RxCUI 836368

200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler [Atrovent] — RxCUI 836368

RxNorm drug concept · Semantic branded drug
RxCUI 836368 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI836368
Official name200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler [Atrovent]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAtrovent 0.017 MG/ACTUAT Metered Dose Inhaler, 200 ACTUAT; Atrovent HFA 17 MCG/INHAL Metered Dose Inhaler, 200 Actuations; 200 ACTUAT Atrovent HFA 0.017 MG/ACTUAT Metered Dose Inhaler; Atrovent HFA 17 MCG per ACTUAT Metered Dose Inhaler, 200 ACTUAT
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)93,758 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ipratropium Nasal Spray: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Unfortunately, no. Ipratropium nasal spray is designed specifically to reduce a runny nose — it blocks the glands that produce nasal fluid. It doesn't do anything for congestion or...
  • Will this spray help with my stuffiness and sneezing too?
  • You can expect to notice a reduction in nasal dripping within about an hour of your first dose — that's what clinical studies showed. Use it consistently as directed throughout the...
  • That depends on why you're using it. For a cold, safety and effectiveness have only been established for up to four days. For seasonal allergies, it's been studied for up to three...
📖 Read our full Ipratropium Nasal Spray guide →

🕸️ Concept Web — How 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT M... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler [Atrovent] RxCUI 836368

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Ipratropium 7213
    • Ipratropium bromide 203212
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Atrovent 151390
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ipratropium Metered Dose Inhaler 746447
    • Ipratropium bromide Metered Dose Inhaler 2645968
    • Ipratropium Inhalant Product 1158614
    • Ipratropium bromide Inhalant Product 2663525
    • Ipratropium Metered Dose Inhaler [Atrovent] 746449
    • Ipratropium bromide Metered Dose Inhaler [Atrovent] 2654983
    • Atrovent Inhalant Product 1173573
    • Metered Dose Inhaler 721654
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler SCD · 836343
  • Ipratropium bromide 0.017 MG/ACTUAT SCDC · 836342
  • Ipratropium Metered Dose Inhaler SCDF · 746447
  • Ipratropium bromide Metered Dose Inhaler SCDFP · 2645968
  • Ipratropium Inhalant Product SCDG · 1158614
  • Ipratropium bromide Inhalant Product SCDGP · 2663525

Brand-Name Concepts

  • Ipratropium bromide 0.017 MG/ACTUAT [Atrovent] SBDC · 836367
  • Ipratropium Metered Dose Inhaler [Atrovent] SBDF · 746449
  • Ipratropium bromide Metered Dose Inhaler [Atrovent] SBDFP · 2654983
  • Atrovent Inhalant Product SBDG · 1173573
  • Atrovent BN · 151390

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 836368 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00597-0087-17 1 CANISTER in 1 CARTON (0597-0087-17) / 200 AEROSOL, METERE... Atrovent HFA Boehringer Ingelheim Pharmaceuticals, Inc. 2005-05-01
Observed labelers: Boehringer Ingelheim Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$22.7663
Range $22.7663–$22.7663 · middle 50% $22.7663–$22.7663 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.